Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma
出版年份 2018 全文链接
标题
Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma
作者
关键词
-
出版物
JOURNAL OF ORAL PATHOLOGY & MEDICINE
Volume 47, Issue 5, Pages 492-501
出版商
Wiley
发表日期
2018-03-25
DOI
10.1111/jop.12707
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oct4 induces EMT through LEF1/β-catenin dependent WNT signaling pathway in hepatocellular carcinoma
- (2017) Lu Sun et al. Oncology Letters
- Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma
- (2017) Souvick Roy et al. CELLULAR ONCOLOGY
- The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells
- (2017) Isabelle Corre et al. Oncotarget
- Clinico-Pathological Correlation of β-Catenin and Telomere Dysfunction in Head and Neck Squamous Cell Carcinoma Patients
- (2015) Swatishree Padhi et al. Journal of Cancer
- Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade
- (2014) X. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p38MAPK Plays a Crucial Role in Stromal-Mediated Tumorigenesis
- (2014) E. Alspach et al. Cancer Discovery
- Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK
- (2013) Lorena Pereira et al. EMBO Molecular Medicine
- A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis
- (2013) Kantima Leelahavanichkul et al. Molecular Oncology
- SOX2 Targets Fibronectin 1 to Promote Cell Migration and Invasion in Ovarian Cancer: New Molecular Leads for Therapeutic Intervention
- (2013) Xiaoyan Lou et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel
- (2012) Sheng-Chieh Tseng et al. BIOCHEMICAL PHARMACOLOGY
- Cancer stem cells and drug resistance: the potential of nanomedicine
- (2012) Serguei Vinogradov et al. Nanomedicine
- Deadly Teamwork: Neural Cancer Stem Cells and the Tumor Microenvironment
- (2011) Justin D. Lathia et al. Cell Stem Cell
- Inhibition of p38 MAPK-Dependent Excision Repair Cross-Complementing 1 Expression Decreases the DNA Repair Capacity to Sensitize Lung Cancer Cells to Etoposide
- (2011) M.-S. Tsai et al. MOLECULAR CANCER THERAPEUTICS
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- A Chemical Genetic Approach Reveals That p38α MAPK Activation by Diphosphorylation Aggravates Myocardial Infarction and Is Prevented by the Direct Binding of SB203580
- (2009) Sarawut Kumphune et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started